Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Depreciation and Depletion (2016 - 2023)

Tg Therapeutics has reported Depreciation and Depletion over the past 8 years, most recently at $73000.0 for Q3 2023.

  • Quarterly results put Depreciation and Depletion at $73000.0 for Q3 2023, down 3.95% from a year ago — trailing twelve months through Sep 2023 was $246000.0 (down 20.65% YoY), and the annual figure for FY2022 was $303000.0, up 7.45%.
  • Depreciation and Depletion for Q3 2023 was $73000.0 at Tg Therapeutics, up from $32000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for TGTX hit a ceiling of $80000.0 in Q4 2021 and a floor of $23000.0 in Q1 2019.
  • Median Depreciation and Depletion over the past 5 years was $59000.0 (2021), compared with a mean of $53473.7.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 97.06% in 2021 and later crashed 58.97% in 2023.
  • Tg Therapeutics' Depreciation and Depletion stood at $28000.0 in 2019, then skyrocketed by 89.29% to $53000.0 in 2020, then surged by 50.94% to $80000.0 in 2021, then dropped by 8.75% to $73000.0 in 2022, then changed by 0.0% to $73000.0 in 2023.
  • The last three reported values for Depreciation and Depletion were $73000.0 (Q3 2023), $32000.0 (Q2 2023), and $68000.0 (Q1 2023) per Business Quant data.